|Articles|February 7, 2008

Merial drug adds claims

Previcox controls pain and inflammation.

Merial announced that the company has received FDA approval to expand the label claim for Previcox, a canine osteoarthritis pain reliever. The expanded label claim includes the control of postoperative pain and inflammation associated with soft-tissue surgery in dogs. For more, visit previcox.com.

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Related to this article

September 23rd, 2026

Clinic center: Boehringer Ingelheim opens new US animal health headquarters in Georgia, Purina unveils $550 million pet food manufacturing facility in Ohio, and more

The latest updates relating to animal care establishments and platforms.

September 21st, 2026

Recent acquisitions: IDEXX buys CoVet, The Farmer's Dog acquires Woof

Two notable pet-industry acquisitions closed in September. One bringing AI-powered clinical documentation into IDEXX's software ecosystem, the other marking the first acquisition for fresh-food brand The Farmer's Dog.

September 21st, 2026

Paws and profits: Schwarzman AMC names zoological department head, Mars names chief digital and information officer, and more updates

New leadership moves, recognition, and achievement.

Merial drug adds claims

Related to this article

Trending on dvm360

New species discovered in Bolivia is first cat described in more than 100 years

A catastrophic miscarriage of justice: The truth about Toxoplasma gondii risk from household cats

Laverdia now available for purchase for dogs with lymphoma

FelineVMA launches free resource center to help practices ease feline visit stress

Q24h